Related Experiment Video
Updated: Mar 29, 2026

Examination of Anatomical Features of Retinal Ganglion Cells Under N-methyl-D-aspartic Acid (NMDA)-induced Excitotoxicity
Published on: September 19, 2025
NMDA Receptors Containing the GluN2D Subunit Control Neuronal Function in the Subthalamic Nucleus
Sharon A Swanger1, Katie M Vance1, Jean-François Pare2
1Department of Pharmacology and.
The GluN2D subunit of the NMDA receptor is crucial for synaptic activity in the subthalamic nucleus (STN). Targeting these NMDA receptors may offer new treatments for neurological disorders like Parkinson's disease.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- The N-methyl-D-aspartate (NMDA) receptor's GluN2D subunit is found in basal ganglia nuclei, but its function is unclear.
- Understanding NMDA receptor subunit roles is vital for neuropharmacology.
Purpose of the Study:
- To investigate the expression and function of GluN2D-containing NMDA receptors in the rat subthalamic nucleus (STN).
- To explore the therapeutic potential of targeting these receptors for neurological disorders.
Main Methods:
- Western blotting and immunoelectron microscopy to detect GluN2D expression in the rat STN.
- Electrophysiological recordings (in vitro and in vivo) using subunit-selective NMDA receptor modulators.
- Analysis of excitatory postsynaptic currents (EPSCs) and neuronal firing rates.
Main Results:
- GluN2D is expressed in the rat STN throughout development and adulthood, localized to various neuronal compartments.
- NMDA receptors containing GluN2B and GluN2D subunits mediate synaptic activity in the STN.
- GluN2D-containing NMDA receptors influence the slow deactivation of EPSCs and modulate STN output.
Conclusions:
- GluN2B and GluN2D NMDA receptor subunits are key players in STN synaptic function.
- These subunits represent potential therapeutic targets for modulating subthalamic neuron activity in Parkinson's disease and other neurological conditions.
More Related Videos
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Antiepileptic Drugs: Glutamate Antagonists
Diencephalon: Thalamus and Information Relay
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

